Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a pill replace chemo for some breast cancer patients?

NCT ID NCT03283384

First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 27 times

Summary

This study is for postmenopausal women with a common type of breast cancer (hormone receptor positive, HER2 negative) that hasn't spread. It compares the usual chemotherapy before surgery to a combination of two targeted pills (ribociclib and letrozole). The goal is to see if the pills can stop cancer cell growth as well as or better than chemo. About 100 women will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Academisch Ziekenhuis Maastricht

    Maastricht, Netherlands

  • Amphia Ziekenhuis

    Breda, Netherlands

  • Antonius Ziekenhuis

    Sneek, Netherlands

  • Bravis Ziekenhuis

    Roosendaal, Netherlands

  • Canisius-Wilhelmina Ziekenhuis

    Nijmegen, Netherlands

  • Catharina Ziekenhuis

    Eindhoven, Netherlands

  • Elisabeth Tweesteden Ziekenhuis

    Tilburg, Netherlands

  • Gelre Ziekenhuizen

    Apeldoorn, Netherlands

  • Groene Hart Ziekenhuis

    Gouda, Netherlands

  • HAGA Ziekenhuis

    The Hague, Netherlands

  • Haaglanden Medisch Centrum

    The Hague, Netherlands

  • Isala

    Zwolle, Netherlands

  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, Netherlands

  • Laurentius Ziekenhuis

    Roermond, Netherlands

  • Leiden University Medical Center

    Leiden, Netherlands

  • Maxima Medisch Centrum

    Eindhoven, Netherlands

  • Nederlands Kanker Instituut - Antoni van Leeuwenhoek

    Amsterdam, Netherlands

  • Onze Lieve Vrouwe Gasthuis

    Amsterdam, Netherlands

  • Spaarne Gasthuis

    Haarlem, Netherlands

  • Stichting Deventer Ziekenhuisgroep

    Deventer, Netherlands

  • Stichting Reinier Haga Groep (Reinier de Graaf Gasthuis)

    Delft, Netherlands

  • Streekziekenhuis Koningin Beatrix

    Winterswijk, Netherlands

  • Tergooi Ziekenhuizen

    Hilversum, Netherlands

  • VieCuri Medisch Centrum

    Venlo, Netherlands

  • Westfriesgasthuis

    Hoorn, Netherlands

  • Ziekenhuis Amstelland

    Amstelveen, Netherlands

  • Ziekenhuis Rivierenland

    Tiel, Netherlands

  • Ziekenhuis St. Jansdal

    Harderwijk, Netherlands

  • Ziekenhuisgroep Twente

    Almelo, Netherlands

Conditions

The condition(s) this trial relates to.

breast neoplasm hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.